A clinic-based cross-sectional comparison found higher anxiety and impulsivity among benzodiazepine users, without resolving the direction of the relationship.
Who was compared
The study recruited patients at a methadone maintenance clinic in Ningbo, China. After exclusions, 71 were analyzed: 39 with benzodiazepine use and 32 without. Participants completed questionnaires addressing use, anxiety, depression, impulsivity, and quality of life.
Several unadjusted differences were observed. After adjustment for selected confounders, benzodiazepine use remained associated with higher anxiety and greater total impulsivity. Those findings describe a relationship between characteristics measured in the same clinical period.
Why causation cannot be assigned
People with greater anxiety or sleep problems may be more likely to use benzodiazepines. Other clinical differences may influence both exposure and questionnaire scores. A cross-sectional design cannot determine whether the benzodiazepine preceded, followed, or independently caused the measured characteristics.
Self-report introduces recall and social-desirability concerns, while the small single-clinic sample limits generalization. Because recruitment deliberately included users and nonusers, the group proportions should not be treated as the prevalence of benzodiazepine use in all methadone patients. For an individual assessment, separate treatment indication, source of the drug, actual use, and observed behavior.
Source paper
Original analysis of the supplied journal article, identified as PMC12949567.
Leave a Reply